Selected Publications

Bolan PO, Zviran A, Brenan L, Schiffman JS, Duasj N, Goodale A,  Piccioni F, Johannessen CM, Landau DAGenotype-Fitness Maps of EGFR-Mutant Lung Adenocarcinoma Chart the Evolutionary Landscape of Resistance for Combination Therapy Optimization.  Cell Systems, 2019.

Cheng Y, Luo H, Izzo F, Pickering BF, Nguyen D, Myers R,  Schurer A, Gourkanti S, Bruning JC, Vu LP, Jaffrey S, Landau DA, Kharas MG. m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment.  Cell Reports, 2019.

 

Nam AS, Kim KT, Chaligne R, Izzo F, Ang C, Taylor J, Myers RM, Abu-Zeinah G, Brand R, Omans ND, Alonso A, Sheridan C, Mariani M, Dai X, Harrington E, Pastore A, Cubillo-Ruiz JR, Tam W, Hoffman R, Rabadan R, Scandura JM, Abdel-Wahab O, Smibert P and Landau DA Somatic mutations and cell identity linked by Genotyping of Transcriptomes.  Nature, 2019.

Gaiti F, Chaligne R, Gu H, Brand RM, Kothen-Hill S, Schulman RC, Grigorev K, Risso D, Kim KT, Huang KY, Pastore A, Alonso ASheridan C, Omans ND, Biederstedt E, Clement K, Wang L, Feldenfeld J, Bhavsar E, Aryee MJ, Allan JN, Furman RR, Gnirke A, Wu CJ, Meissner A and Landau DA .  Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia.  Nature, 2019.

*Highlight in Nature Reviews Genetics

Pastore A, Gaiti F, Lu SX, Brand RM, Kulm S, Chaligne R, Gu H, Huang KY, Stamenova EK, Béguelin WJiang Y, Schulman RC, Kim KT, Alonso A, Allan JN, Furman RR, Gnirke A, Wu CJ, Melnick AM, Meissner A, Bernstein BE, Abdel-Wahab O and Landau DA .  Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL.  Nature Communications, 2019.

*Highlight in Nature Reviews Genetics

Chaligne R, Nam AS, Landau DA.  TARGET-seq Takes Aim at Cancer Evolution through Multi-omics Single-Cell Genotyping and Transcriptomics. Molecular Cell, 2019.

Debnath S, Yallowitz AR, McCormick J, Lalani S, Zhang T, Xu R, Li N, Liu Y, Yang YS, Eiseman M, Shim JH,  Hameed M, Healey JH, Bostrom MP, Landau DA, Greenblatt MB.  ​Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature, 2018

Taylor-Weiner A, Stewart C,  Giordano TMiller MRosenberg MMacbeth ALennon NRheinbay E, Landau DA, Wu CJ, Getz G.  ​DeTiN: overcoming tumor-in-normal contamination. Nature Methods, 2018

Kothen-Hill ST, Zviran A, Schulman R, Maloney D, Huang KY, Omans N, Liao W, Robine N,  & Landau DA. Deep learning mutation prediction enables early stage lung cancer detection in liquie biopsy. Sixth International Conference on Learning Representations, Workshop Track2018.

Landau DA, Sun C, Rosebock D, Herman SEM, Fein J, Sivina M, Underbayev C, Liu D, Hoellenriegel J, Farooqui MZH, Zhang W, Cibulskis C, Zviran A, Neuberg DS, Livitz D, Bozic I, Leshchiner I, Getz G, Burger JA, Wiestner A & Wu CJ. The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy. Nature Communications2017.

 

Bakhoum SF, Landau DA. Cancer Evolution: No Room for Negative Selection. Cell2017.

Sade-Feldman M, Jiao YJ, Chen JH, Rooney MS, Barzily-Rokni M, Eliane JP, Bjorgaard SL, Hammond MR, Vitzthum H, Blackmon SM, Frederick DT, Hazar-Rethinam M, Nadres BA,  Van Seventer EE, Shukla AS, Yizhak K, Ray JP, Rosebrock D, Livitz D, Adalsteinsson V, Getz G, Duncan LM, Li B, Corcoran RB, Lawrence DP, Rachamimov A, Boland GM, Landau DA, Flaherty KT, Sullivan RJ & Hacohen N. Resistance to checkpoint blockade therapy through inactivation of antigen presentation. Nature Communications, 2017 May. 

Bakhoum SF, Landau DA. Chromosomal Instability as a Driver of Tumor Heterogeneity and Evolution. Cold Spring Harb Perspect Med, 2017.

Burger J*, Landau DA*, Taylor-Weiner A*, Bozic I*, Zhang H*, Sarosiek K, Wang L, Stewart C, Fan J, Hoellenriegel J, Sivina M, Dubuc A, Fraser C, Han Y, Li S, Livak KJ, Zou L,  Wan Y, Konoplev S, Cibulskis C, Brown J, Abruzzo LV, Carter S, Keating M, Davids M,  Wierda WG, Cibulskis K, Zenz T, Werner L, Dal Cin P, Kharchenko P, Neuberg D, Kantarjian H, Lander ES, Gabriel S, O'Brien S, Letai A, Weitz D, Nowak M, Getz G, and Wu CJ. Clonal evolution in patients with chronic lymphocytic leukemia developing resistance to BTK inhibition. Nature Communications, 2016. 

Izzo F, Landau DA. Genetic and Epigenetic Determinants of B-cell Lymphoma Evolution. Current Opinion in Hematology, 2016.

Edelmann J, Tausch E, Landau DA, Robrecht S, Bahlo J, Fischer K, Fink AM, Bloehdorn J, Holzmann K, Böttcher S, Werner L, Kneba M, Gribben JG, Neuberg DS, Wu CJ, Hallek M, Döhner H, Stilgenbauer S. Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial. Leukemia.

Wang LBrooks ANFan JWan YGambe RLi SHergert SYin SFreeman SSLevin JZFan LSeiler MBuonamici SSmith PGChau KFCibulskis CLZhang WRassenti LZGhia EMKipps TJFernandes SBloch DBKotliar DLandau DAShukla SAAster JCReed RDeLuca DBrown JRNeuberg DGetz GLivak KJMeyerson MMKharchenko PVWu CJ. Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia. Cancer Cell, 2016.

Manier S, Salem K, Park J, Landau DA, Getz G, Ghobrial I. Genomic complexity in Multiple Myeloma and its clinical implication. Nature Reviews Clinical Oncology, 2016.

 

Landau DA*, Tausch E*, Taylor-Weiner AN*, Stewart C, Reiter JG, Bahlo J, Kluth S, Bozic I, Lawrence M, Bottcher S, Cibulskis K, Mertens D, Sougnez C, Rosenberg M, Hess JM, Carter SL, Edelmann J, Kless S, Fink A, Fischer K, Gabriel S, Lander ES, Nowak MA, Dohner H, Hallek M, Neuberg D, Getz G*, Stilgenbauer S*, Wu CJ*. Mutations driving CLL and their evolution in progression and relapse. Nature, 2015. 

 

Landau DA*, Clement K*, Ziller MZ, Boyle P, Fan J, Gu H, Stevenson K, Sougnez C, Wang L, Li S, Zhang W, Ghandi M, Garraway G, Fernandes SM, Livak KJ, Gabriel S, Gnirke A, Lander ES, Brown JR, Neuberg D, Kharchenko PV, Hacohen N, Getz G*, Meissner A*, Wu CJ*. Locally disordered methylation forms the basis of intra-tumor methylome variation in chronic lymphocytic leukemia. Cancer Cell, 2014.

Comment: Cancer Cell. 

 

Landau DA, Carter SL, Getz G, Wu CJ. Clonal evolution in hematologic malignancies and therapeutic implications. Leukemia, 2014.

 

Gress RA, Miller JS, Battiwalla M, Bishop MR, Giralt SA, Hardy NM, Kroger N, Wayne AS, Landau DA, Wu CJ. Proceedings from the National Cancer Institute¹s Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: Biology of Relapse after Transplantation. BBMT 2013.

 

Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, Kiezun A, Hammerman PS, McKenna A, Drier Y, Zou L, Ramos AH, Pugh TJ, Stransky N, Helman E, Kim J, Sougnez C, Ambrogio L, Nickerson E, Shefler E, Cortés ML, Auclair D, Saksena G, Voet D, Noble M, DiCara D, Lin P, Lichtenstein L, Heiman DI, Fennell T, Imielinski M, Hernandez B, Hodis E, Baca S, Dulak AM, Lohr J, Landau DA, Wu CJ, Melendez-Zajgla J, Hidalgo-Miranda A, Koren A, McCarroll SA, Mora J, Lee RS, Crompton B, Onofrio R, Parkin M, Winckler W, Ardlie K, Gabriel SB, Roberts CW, Biegel JA, Stegmaier K, Bass AJ, Garraway LA, Meyerson M, Golub TR, Gordenin DA, Sunyaev S, Lander ES, Getz G. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature, 2013.

 

Landau DA, Wu CJ. Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics. Genome Medicine, 2013.

 

Landau DA*, Carter SL*, Stojanov P*, McKenna A, Stevenson K, Lawrence MS, Sougnez C, Stewart C, Sivachenko A, Wang L, Wan Y, Zhang W, Shukla SA, Vartanov A, Fernandes SM, Saksena G, Cibulskis K, Tesar B, Gabriel S, Hacohen N, Meyerson M, Lander ES, Neuberg D, Brown JR, Getz G*, Wu CJ*. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell, 2013.

Comment: Nature Genetics, Nature Reviews Cancer, Nature Medicine: Notable advances 2013.

Full List of Publications

PubMed